FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula XII, where the values of Ra, Rb, R2, R7 and X are as defined in the claims, or a pharmaceutically acceptable salt thereof. 
.
EFFECT: compound of the invention has neprilysin (NEP) inhibition activity and is intended for the preparation of a medicament for treating hypertension, heart failure or kidney disease.
28 cl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITORS OF NONPRILYZINE | 2011 |
|
RU2622288C2 |
| NEPRILYSIN INHIBITORS | 2012 |
|
RU2629930C2 |
| SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS | 2012 |
|
RU2604522C2 |
| NEPRILYSIN INHIBITORS | 2011 |
|
RU2605557C2 |
| NEPRILYSIN INHIBITORS | 2013 |
|
RU2650114C2 |
| NEW PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AND APPLICATION THEREOF | 2014 |
|
RU2621709C2 |
| β-D-2ʹ-DEOXY-2ʹ-α-FLUORO-2ʹ-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR TREATMENT OF DISEASES CAUSED BY HCV | 2016 |
|
RU2764767C2 |
| DUAL-ACTING ANTIHYPERTENSIVE COMPOUNDS, METHODS FOR PREPARING THEM, BASED PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE COMPOUNDS | 2008 |
|
RU2476427C2 |
| COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
| PRINCE REACTION AND INTERMEDIATE PRODUCTS USED IN SYNTHESIS OF HALICHONDRIN MACROLIDES AND THEIR ANALOGUES | 2017 |
|
RU2777913C2 |
